{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:09:33Z","timestamp":1781104173565,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100009687","name":"Wroclaw Medical University","doi-asserted-by":"crossref","award":["ST808"],"award-info":[{"award-number":["ST808"]}],"id":[{"id":"10.13039\/501100009687","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.pharep.2017.05.002","type":"journal-article","created":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T12:32:04Z","timestamp":1494678724000},"page":"1113-1119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Oral administration of kaempferol inhibits bone loss in rat model of ovariectomy-induced osteopenia"],"prefix":"10.1007","volume":"69","author":[{"given":"Beata","family":"Nowak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Matuszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nikodem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Filipiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Landw\u00f3jtowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Sadanowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"J\u0119drzejuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rzeszutko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Zduniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Piasecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Dziewiszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Merwid-L\u0105d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Trocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Soza\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kwiatkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Bolanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Szel\u0105g","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"4","key":"10.1016\/j.pharep.2017.05.002_bib0005","first-page":"365","article-title":"Drugs for the management of osteoporosis: a review","volume":"51","author":"Khajuria","year":"2011","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.pharep.2017.05.002_bib0010","series-title":"Rheumatology great internal medicine","author":"Puszczewicz","year":"2011"},{"issue":"10","key":"10.1016\/j.pharep.2017.05.002_bib0015","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1002\/art.22117","article-title":"Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis","volume":"54","author":"van Staa","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.pharep.2017.05.002_bib0020","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s11926-010-0097-y","article-title":"The societal burden of osteoporosis","volume":"12","author":"Becker","year":"2010","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.pharep.2017.05.002_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4081\/reumatismo.2016.870","article-title":"Guidelines for the diagnosis, prevention and management of osteoporosis","volume":"68","author":"Rossini","year":"2016","journal-title":"Reumatismo"},{"issue":"1","key":"10.1016\/j.pharep.2017.05.002_bib0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjmed.2012.06.023","article-title":"Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday","volume":"126","author":"McClung","year":"2013","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.pharep.2017.05.002_bib0035","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/1060028016649368","article-title":"Identification of risk factors for bisphosphonate-associated atypical femoral fractures and osteonecrosis of the jaw in a pharmacovigilance database","volume":"50","author":"Bejhed","year":"2016","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.pharep.2017.05.002_bib0040","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.pharep.2017.05.002_bib0045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.pharep.2017.05.002_bib0050","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jocd.2013.09.018","article-title":"Understanding and communicating the benefits and risks of denosumab, raloxifene, and teriparatide for the treatment of osteoporosis","volume":"17","author":"Lewiecki","year":"2014","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.pharep.2017.05.002_bib0055","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jep.2014.09.032","article-title":"Cuscuta chinensis lam.: a systematic review on ethnopharmacology, phytochemistry and pharmacology of an important traditional herbal medicine","volume":"157","author":"Donnapee","year":"2014","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.pharep.2017.05.002_bib0060","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jep.2011.03.056","article-title":"Antiosteoporotic compounds from seeds of cuscuta chinensis","volume":"135","author":"Yang","year":"2011","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2017.05.002_bib0065","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mce.2009.01.011","article-title":"Effects of egb 761 on bone mineral density, bone microstructure, and osteoblast function: possible roles of quercetin and kaempferol","volume":"302","author":"Trivedi","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"10.1016\/j.pharep.2017.05.002_bib0070","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.febslet.2009.01.030","article-title":"Kaempferol is an estrogen-related receptor alpha and gamma inverse agonist","volume":"583","author":"Wang","year":"2009","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.pharep.2017.05.002_bib0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0006-2952(02)01445-4","article-title":"Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption","volume":"65","author":"Wattel","year":"2003","journal-title":"Biochem Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2017.05.002_bib0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mce.2008.02.027","article-title":"Kaempferol has osteogenic effect in ovariectomized adult sprague-dawley rats","volume":"289","author":"Trivedi","year":"2008","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.pharep.2017.05.002_bib0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.advms.2015.09.001","article-title":"The influence of bexarotene, a selective agonist of the retinoid receptor x (rxr), and tazarotene, a selective agonist of the retinoid acid receptor (rar), on bone metabolism in rats","volume":"61","author":"Nowak","year":"2016","journal-title":"Adv Med Sci"},{"issue":"1","key":"10.1016\/j.pharep.2017.05.002_bib0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the asbmr histomorphometry nomenclature committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.pharep.2017.05.002_bib0095","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s10753-014-9849-6","article-title":"Kaempferol inhibits IL-1\u03b2-stimulated, rankl-mediated osteoclastogenesis via downregulation of mapks, c-fos, and nfatc1","volume":"37","author":"Lee","year":"2014","journal-title":"Inflammation"},{"issue":"6","key":"10.1016\/j.pharep.2017.05.002_bib0100","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.bcp.2005.12.023","article-title":"Differential activity of kaempferol and quercetin in attenuating tumor necrosis factor receptor family signaling in bone cells","volume":"71","author":"Pang","year":"2006","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.pharep.2017.05.002_bib0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.pharep.2017.05.002_bib0110","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.pharep.2017.05.002_bib0115","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.bcp.2003.11.009","article-title":"Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in mg-63 human osteoblasts through erk and estrogen receptor pathway","volume":"67","author":"Prouillet","year":"2004","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.pharep.2017.05.002_bib0120","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bone.2010.05.001","article-title":"Effects of soy isoflavone supplements on bone turnover markers in menopausal women: systematic review and meta-analysis of randomized controlled trials","volume":"47","author":"Taku","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.pharep.2017.05.002_bib0125","article-title":"Soy reduces bone turnover markers in women during early menopause\u2013a randomized controlled trial","author":"Sathyapalan","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.pharep.2017.05.002_bib0130","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bone.2004.03.031","article-title":"Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice","volume":"35","author":"Fonseca","year":"2004","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.pharep.2017.05.002_bib0135","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.nutres.2014.05.003","article-title":"Systematic review and meta-analysis of the bone protective effect of phytoestrogens on osteoporosis in ovariectomized rats","volume":"34","author":"Fu","year":"2014","journal-title":"Nutr Res"},{"issue":"6","key":"10.1016\/j.pharep.2017.05.002_bib0140","first-page":"599","article-title":"Effects of low doses of hydrochloride tetracycline on bone metabolism and uterus in ovariectomized rats","volume":"24","author":"Li","year":"2003","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"10.1016\/j.pharep.2017.05.002_bib0145","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00774-007-0830-4","article-title":"Effects of genistein on vertebral trabecular bone microstructure, bone mineral density, microcracks, osteocyte density, and bone strength in ovariectomized rats","volume":"26","author":"Dai","year":"2008","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"10.1016\/j.pharep.2017.05.002_bib0150","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1089\/jmf.2009.0059","article-title":"Combination of genistin and fructooligosaccharides prevents bone loss in ovarian hormone deficiency","volume":"13","author":"Hooshmand","year":"2010","journal-title":"J Med Food"},{"issue":"3","key":"10.1016\/j.pharep.2017.05.002_bib0155","first-page":"136","article-title":"Kaempferol exhibits progestogenic effects in ovariectomized rats","volume":"5","author":"Toh","year":"2014","journal-title":"J Steroids Horm Sci"},{"key":"10.1016\/j.pharep.2017.05.002_bib0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jnutbio.2015.09.027","article-title":"Treatment with kaempferol suppresses breast cancer cell growth caused by estrogen and triclosan in cellular and xenograft breast cancer models","volume":"28","author":"Kim","year":"2016","journal-title":"J Nutr Biochem"},{"issue":"1","key":"10.1016\/j.pharep.2017.05.002_bib0165","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/13697137.2012.679168","article-title":"Do extracts of oral soybean augment the trophic effect of estrogen on the rat uterus?","volume":"16","author":"Francisco","year":"2013","journal-title":"Climacteric"},{"key":"10.1016\/j.pharep.2017.05.002_bib0170","first-page":"63","article-title":"Genistein treatment increases bone mass in obese, hyperglycemic mice","volume":"9","author":"Michelin","year":"2016","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"2","key":"10.1016\/j.pharep.2017.05.002_bib0175","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/jn\/136.2.409","article-title":"Genistein decreases food intake, body weight, and fat pad weight and causes adipose tissue apoptosis in ovariectomized female mice","volume":"136","author":"Kim","year":"2006","journal-title":"J Nutr"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016302389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016302389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:08Z","timestamp":1752611828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2017.05.002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1734114016302389"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2017.05.002","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral administration of kaempferol inhibits bone loss in rat model of ovariectomy-induced osteopenia","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2017.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}